Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
France
/
Healthcare
Create a narrative
Healthcare French Community
Our community narratives are driven by numbers and valuation.
Create a narrative
All companies
Popular
Undervalued
Overvalued
Healthcare French Investing Ideas
EssilorLuxottica Société anonyme
LO
London_Investment_Analysts
Community Contributor
EssilorLuxottica: Pioneering the Future of Eyewear through Innovation and Strategic Expansion
EssilorLuxottica, a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, continues to redefine the eyewear industry through technological innovation and strategic acquisitions. With a diverse portfolio that includes iconic brands like Oakley and the recent addition of Supreme, the company is poised to enhance its market presence and consumer engagement.
View narrative
€400.08
FV
37.6% undervalued
intrinsic discount
13.65%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
5 months ago
author updated this narrative
Cegedim
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Visiodent Integration And Allianz Contract Will Improve Future Profitability In Healthcare Software
Key Takeaways Internalizing the workforce, especially for Allianz, could cut external costs and boost profitability. The simpler software launch may enhance market share and revenue within the French healthcare software market.
View narrative
€14.00
FV
24.6% undervalued
intrinsic discount
3.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Cegedim
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Legacy Challenges Will Test Healthcare Digitalization As Modest Opportunities Open
Key Takeaways Legacy IT reliance and underperformance in core divisions constrain growth, as newer digital competitors erode market share and hinder innovation. Limited international success and tightening regulatory demands restrict diversification, keeping growth dependent on mature home markets and pressuring profitability.
View narrative
€11.00
FV
4.1% undervalued
intrinsic discount
4.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
bioMérieux
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Continued Innovation And Market Leadership Will Ensure Future Success
Key Takeaways Strong cross-selling and innovation strategies are driving revenue growth and expanding market leadership in panel and instrument installations. Profitability improvements through automation and R&D investment are enhancing margins and supporting sustainable long-term growth.
View narrative
€123.54
FV
1.4% overvalued
intrinsic discount
7.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
Cegedim
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Healthcare Digitization And AI Analytics Will Expand Market Access
Key Takeaways Migration of operations to Morocco and enhanced cost control are expected to significantly improve long-term margins and sustain operating income growth. Cloud investments, AI integration, and compliance-ready solutions position Cegedim for leadership in healthcare digitization, supporting high-margin, recurring revenue streams and market share gains.
View narrative
€17.00
FV
37.9% undervalued
intrinsic discount
4.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
EssilorLuxottica Société anonyme
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Shrinking Demographics And E-Commerce Will Undermine Eyewear Value
Key Takeaways Market dynamics like shrinking demand, income inequality, and disruptive technologies threaten revenue growth, volume opportunities, and long-term profitability. Increased competition from e-commerce and risks in brand licensing may erode market share, price power, and operating margins over time.
View narrative
€192.19
FV
29.9% overvalued
intrinsic discount
6.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
EssilorLuxottica Société anonyme
AN
AnalystHighTarget
Consensus Narrative from 18 Analysts
Aging Global Demographics And Smart Eyewear Will Transform Vision
Key Takeaways Smart eyewear innovation and healthtech expansion position EssilorLuxottica as a leader beyond traditional eyewear, driving profit margins and diversified revenue streams. Vertical integration, global brand strength, and technological advancements create resilience, superior pricing power, and lasting high-growth potential across markets.
View narrative
€300.00
FV
16.8% undervalued
intrinsic discount
7.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
CLAR
Clariane
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Refinancing And French Pricing Will Pressure Margins But Build Resilience
Key Takeaways Ongoing disposal plan and deleveraging efforts may limit opportunistic growth and reduce future revenue streams. Margin pressures and refinancing could impact profitability and financial flexibility, constraining revenue and earnings growth.
View narrative
€4.53
FV
9.5% overvalued
intrinsic discount
4.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
18 days ago
author updated this narrative
EssilorLuxottica Société anonyme
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
Expansion Into Smart Glasses And Med-Tech May Boost Future Earnings Despite High PE Ratios
Key Takeaways Strategic expansion in smart glasses and med-tech could drive revenue growth and improve net margins through higher profit margins and innovative products. Strong potential revenue growth from myopia management lenses in China and Europe, with expansion plans into the U.S. market likely to boost market share.
View narrative
€256.16
FV
2.5% undervalued
intrinsic discount
7.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
27
users have followed this narrative
5 months ago
author updated this narrative
Value any company in seconds
Popular companies